Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
38.74
-0.14 (-0.36%)
At close: Mar 10, 2026
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of $170.98 billion as of March 10, 2026. Its market cap has decreased by -53.80% in one year.
Market Cap
170.98B
Enterprise Value
187.19B
Revenue
48.59B
Ranking
n/a
PE Ratio
10.62
Stock Price
$38.74
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 7.15B to 170.98B, an increase of 2,292.55%. That is a compound annual growth rate of 11.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 175.40B | -22.95% |
| Dec 30, 2025 | 227.63B | -41.00% |
| Dec 30, 2024 | 385.82B | -16.41% |
| Dec 29, 2023 | 461.55B | 51.61% |
| Dec 30, 2022 | 304.43B | 19.34% |
| Dec 30, 2021 | 255.09B | 56.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 791.42M |
| Veradigm | 724.25M |
| Glass House Brands | 718.57M |
| Elite Pharmaceuticals | 429.68M |
| American Oncology Network | 360.64M |
| Northwest Biotherapeutics | 360.57M |
| CytoDyn | 296.04M |
| Silence Therapeutics | 294.27M |